Keene, New Hampshire, United States Harbor Light Capital Partners is the famous VC, which was founded in 1911. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Keene.
The overall number of key employees were 2.
The high activity for fund was in 2011. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2000. This Harbor Light Capital Partners works on 22 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations.
Among the various public portfolio startups of the fund, we may underline Vets First Choice, Courtagen Life Sciences, EnerTrac We can highlight the next thriving fund investment areas, such as Pharmaceutical, Life Science. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Harbor Light Capital Partners, startups are often financed by Pittsburgh Life Sciences Greenhouse, Oxford Bioscience Partners, Innovation Works. The meaningful sponsors for the fund in investment in the same round are Pittsburgh Life Sciences Greenhouse, BlueTree Allied Angels, Newlin Investment Company. In the next rounds fund is usually obtained by Innovation Works, Pittsburgh Life Sciences Greenhouse, Jay Yue.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Comercia Global Payments | Barcelona, Catalonia, Spain |
| ESCO Technologies Inc. | Missouri, St Louis, United States |
| Fair Ventures | - |
| Greystone Managed Investments | Canada, Regina, Saskatchewan |
| Hawk Equity | New York, New York, United States |
| HDGL | - |
| JAFCO Group | - |
| Kemexel Ventures (KEMEXEL GROUP COMPANIES) | - |
| Lakeshore ArchAngels | Chicago, Illinois, United States |
| MAGS Capital | Beijing, China, Haidian |
| Matilda Media Group | New York, New York, United States |
| Platinum Equity | Beverly Hills, California, United States |
| RP Global | France, Lille, Nord-Pas-de-Calais |
| Shiwei Venture Capital | China, Hangzhou, Zhejiang |
| StartLife | Gelderland, Netherlands, Wageningen |
| Telama Investment | - |
| Thieme | New York, New York, United States |
| Toray Industries | Japan, Tokyo |
| Tucker Anthony Sutro | Boston, Massachusetts, United States |
| Zhitou Touzi | China, Fujian, Xiamen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Carmell Therapeutics | $4M | 11 Jul 2017 | United States, Pittsburgh | ||
Senet | $18M | 22 Jun 2015 | New Hampshire, United States | ||
Carmell Therapeutics | $681K | 13 Jun 2014 | Pittsburgh, Pennsylvania, United States | ||
Alcyone Lifesciences | $4M | 15 Jan 2014 | Massachusetts, United States | ||
EnerTrac | 18 Jul 2013 | New Hampshire, United States | |||
Courtagen Life Sciences | $8M | 18 Oct 2011 | Woburn, Massachusetts, United States | ||
Carmell Therapeutics | $2M | 18 Apr 2011 | Pittsburgh, Pennsylvania, United States | ||
Micronotes | $1M | 10 Jun 2010 | Boston, Massachusetts, United States | ||
FetchDog | $4M | 11 Feb 2009 | Portland, Maine, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Carmell Therapeutics | $4M | 11 Jul 2017 | United States, Pittsburgh | ||
Senet | $18M | 22 Jun 2015 | New Hampshire, United States | ||
Carmell Therapeutics | $681K | 13 Jun 2014 | Pittsburgh, Pennsylvania, United States | ||
Alcyone Lifesciences | $4M | 15 Jan 2014 | Massachusetts, United States | ||
EnerTrac | 18 Jul 2013 | New Hampshire, United States | |||
Courtagen Life Sciences | $8M | 18 Oct 2011 | Woburn, Massachusetts, United States | ||
Carmell Therapeutics | $2M | 18 Apr 2011 | Pittsburgh, Pennsylvania, United States | ||
Micronotes | $1M | 10 Jun 2010 | Boston, Massachusetts, United States | ||
FetchDog | $4M | 11 Feb 2009 | Portland, Maine, United States |
